U.S. market Closed. Opens in 1 day 14 hours 5 minutes

ACGN | Aceragen, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue4.86MN/AN/A1.45M662.00K
Cost of RevenueN/AN/AN/AN/AN/A
Gross Profit4.86MN/AN/A1.45M662.00K
Operating Expenses24.40M26.35M36.69M47.33M57.26M
Selling, General & Admin12.21M9.98M11.91M12.48M15.42M
Research & Development12.19M16.38M24.77M34.85M41.84M
Other Operating Expenses-2.40M-22.00K134.00K1.11M1.07M
Operating Income-27.82M-27.67M-36.69M-46.07M-60.96M
Other Expenses / Income-10.34M124.44M-75.97M-10.63M-3.28M
Before Tax Income-29.68M98.09M-112.66M-56.52M-59.88M
Income Tax Expenses-6.32M-124.49M76.05M11.62M3.92M
Net Income-23.36M98.09M-112.66M-56.52M-59.88M
Interest ExpensesN/A7.00K3.00KN/A11.00K
Basic Shares Outstanding3.26M2.90M1.99M1.68M1.56M
Diluted Shares Outstanding3.26M2.95M1.99M1.68M1.56M
EBITDA-11.58M-150.81M39.42M-34.14M-52.24M
EBITDA Margin-238.19%0.00%0.00%-2,357.94%-7,891.54%
EBIT-29.68M-26.39M-36.61M-44.89M-55.95M
EBIT Margin-610.41%0.00%0.00%-3,100.28%-8,450.91%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙